Your browser doesn't support javascript.
loading
Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study.
Dos Santos, A; Noury, J-B; Genestet, S; Nadaj-Pakleza, A; Cassereau, J; Baron, C; Videt, D; Michel, L; Pereon, Y; Wiertlewski, S; Magot, A.
Afiliação
  • Dos Santos A; Department of Neurology, University Hospital of Nantes, Nantes, France.
  • Noury JB; Reference Centre for Neuromuscular Diseases AOC, University Hospital of Brest, Brest, France.
  • Genestet S; Reference Centre for Neuromuscular Diseases AOC, University Hospital of Brest, Brest, France.
  • Nadaj-Pakleza A; Reference Centre for Neuromuscular Diseases, University Hospital of Strasbourg, Strasbourg, France.
  • Cassereau J; Reference Centre for Neuromuscular Diseases AOC, University Hospital of Angers, Angers, France.
  • Baron C; Department of Clinical Neurophysiology, University Hospital of Poitiers, Poitiers, France.
  • Videt D; Department of Neurology, Centre Hospitalier Bretagne Atlantique, Vannes, France.
  • Michel L; Department of Neurology, University Hospital of Rennes, Rennes, France.
  • Pereon Y; Reference Centre for Neuromuscular Diseases AOC, University Hospital of Nantes, Nantes, France.
  • Wiertlewski S; Department of Neurology, University Hospital of Nantes, Nantes, France.
  • Magot A; Reference Centre for Neuromuscular Diseases AOC, University Hospital of Nantes, Nantes, France.
Eur J Neurol ; 27(11): 2277-2285, 2020 11.
Article em En | MEDLINE | ID: mdl-32526053

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miastenia Gravis Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miastenia Gravis Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article